Amneal Pharmaceuticals, Inc. 4

Tushar Bhikhubhai Patel indirectly acquired 12,763,469 shares of Amneal Pharmaceuticals Class A Common Stock as stock consideration in the Kashiv BioSciences acquisition.

On August 10, 2026, reporting person Tushar Bhikhubhai Patel, in his capacity as manager of a limited liability company controlled by family trusts, acquired 12,763,469 shares of Amneal Pharmaceuticals, Inc. Class A Common Stock as part of the stock consideration issued in connection with Amneal’s acquisition of Kashiv BioSciences, LLC. The shares, reported as an acquisition in an indirect ownership capacity, increased his indirect beneficial holdings to 61,341,678 Class A shares. The transaction reflects a non‑open‑market, deal-related equity issuance under a Membership Interest Purchase Agreement rather than a discretionary purchase or sale in the public market; the dollar value of the award is substantial but functions primarily as transaction consideration for the sale of Kashiv’s membership interests to an Amneal subsidiary.

Filing Facts

CIK

1723128

Ticker

AMRX

Form

4

Source Type

fda

Accession

0000898432-26-000655

Alert Tier

7